Literature DB >> 29227640

Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma.

Andrea Palermo1, Marco Fosca2, Gaia Tabacco1, Federico Marini3, Valerio Graziani2, Maria Carla Santarsia1, Filippo Longo4, Angelo Lauria1, Roberto Cesareo5, Isabella Giovannoni6, Chiara Taffon6, Massimiliano Rocchia7, Silvia Manfrini1, Pierfilippo Crucitti4, Paolo Pozzilli1, Anna Crescenzi6, Julietta V Rau2.   

Abstract

Primary hyperparathyroidism is an endocrine disorder characterized by autonomous production of parathyroid hormone. Patients with the symptomatic disease should be referred for parathyroidectomy. However, the distinction between the pathological condition and the benign one is very challenging in the surgical setting; therefore, accurate recognition is important to ensure success during minimally invasive surgery. At present, all intraoperative techniques significantly increase surgical time and, consequently, cost. In this proof-of-concept study, Raman microscopy was used to differentiate between healthy parathyroid tissue and parathyroid adenoma from 18 patients. The data showed different spectroscopic features for the two main tissue types of healthy and adenoma. Moreover, the parathyroid adenoma subtypes (chief cells and oxyphil cells) were characterized by their own Raman spectra. The partial least-squares discriminant analysis (PLS-DA) model built to discriminate healthy from adenomatous parathyroid tissue was able to correctly classify all samples in the calibration and validation data sets, providing 100% prediction accuracy. The PLS-DA model built to discriminate chief cell adenoma from oxyphil cell adenoma allowed us to correctly classify >99% of the spectra during calibration and cross-validation and to correctly predict 100% of oxyphil and 99.8% of chief cells in the external validation data set. The results clearly demonstrate the great potential of Raman spectroscopy. The final goal would be development of a Raman portable fiber probe device for intraoperative optical biopsy, both to improve the surgical success rate and reduce surgical cost.

Entities:  

Mesh:

Year:  2017        PMID: 29227640     DOI: 10.1021/acs.analchem.7b03617

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  4 in total

Review 1.  3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Authors:  Mingxue Li; Canrong Wu; Yueying Yang; Mengzhu Zheng; Silin Yu; Jinhui Wang; Lixia Chen; Hua Li
Journal:  Cell Oncol (Dordr)       Date:  2021-03-18       Impact factor: 6.730

2.  Thyroid cancer diagnosis by Raman spectroscopy.

Authors:  Marco Sbroscia; Michael Di Gioacchino; Paolo Ascenzi; Pierfilippo Crucitti; Alessandra di Masi; Isabella Giovannoni; Filippo Longo; Davide Mariotti; Anda Mihaela Naciu; Andrea Palermo; Chiara Taffon; Martina Verri; Armida Sodo; Anna Crescenzi; Maria Antonietta Ricci
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

Review 3.  Preoperative and Intraoperative Methods of Parathyroid Gland Localization and the Diagnosis of Parathyroid Adenomas.

Authors:  Jacek Baj; Robert Sitarz; Marek Łokaj; Alicja Forma; Marcin Czeczelewski; Amr Maani; Gabriella Garruti
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411

Review 4.  How molecular imaging will enable robotic precision surgery : The role of artificial intelligence, augmented reality, and navigation.

Authors:  Thomas Wendler; Fijs W B van Leeuwen; Nassir Navab; Matthias N van Oosterom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-29       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.